Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey

Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA. Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose. AIDS. 2020;34(14):1997–2005.

US Preventive Services Task Force. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;330(8):736–45.

Article  Google Scholar 

Ni Z, Altice FL, Wickersham JA, Copenhaver MM, DiDomizio EE, Nelson LE, et al. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug Alcohol Depend. 2021;219:108477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pleuhs B, Mistler CB, Quinn KG, Dickson-Gomez J, Walsh JL, Petroll AE, et al. Evidence of potential discriminatory HIV Pre-exposure Prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S. J Prim Care Community Health. 2022;13:21501319211063999.

Article  PubMed  PubMed Central  Google Scholar 

Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure Prophylaxis (PrEP) Care Cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490–506.

Article  PubMed  Google Scholar 

Jaiswal J, Griffin M, Hascher K, Cox AB, Dunlap K, Walters S, et al. Logistical facilitators and barriers to PrEP implementation in Methadone Clinic settings: Provider and Staff perspectives. J Addict Med. 2022;16(5):e278–83.

Article  PubMed  PubMed Central  Google Scholar 

Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, et al. Primary Care Physicians’ willingness to prescribe HIV pre-exposure Prophylaxis for people who inject drugs. AIDS Behav. 2017;21(4):1025–33.

Article  PubMed  PubMed Central  Google Scholar 

Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The past, Present, and future of PrEP implementation among people who use drugs. Curr HIV/AIDS Rep. 2021;18(4):328–38.

Article  PubMed  PubMed Central  Google Scholar 

Andrawis A, Tapa J, Vlaev I, Read D, Schmidtke KA, Chow EPF, Lee D, Fairley CK, Ong JJ. Applying behavioural insights to HIV Prevention and Management: a scoping review. Curr HIV/AIDS Rep. 2022;19(5):358–74. https://doi.org/10.1007/s11904-022-00615-z.

Article  PubMed  PubMed Central  Google Scholar 

Reback CJ, Kisler KA, Fletcher JB. A novel adaptation of Peer Health Navigation and Contingency Management for Advancement along the HIV Care Continuum among Transgender women of Color. AIDS Behav. 2021;25(Suppl 1):40–51. https://doi.org/10.1007/s10461-019-02554-0.

Article  PubMed  PubMed Central  Google Scholar 

Alsan M, Beshears J, Armstrong WS, Choi JJ, Madrian BC, Nguyen MLT, Del Rio C, Laibson D, Marconi VC. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS. AIDS. 2017;31(12):1765–9. https://doi.org/10.1097/QAD.0000000000001543.

Article  PubMed  Google Scholar 

Silverman K, Holtyn AF, Rodewald AM, Siliciano RF, Jarvis BP, Subramaniam S, Leoutsakos JM, Getty CA, Ruhs S, Marzinke MA, Fingerhood M. Incentives for viral suppression in people living with HIV: a Randomized Clinical Trial. AIDS Behav. 2019;23(9):2337–46. https://doi.org/10.1007/s10461-019-02592-8.

Article  PubMed  PubMed Central  Google Scholar 

Ribeiro A, Pinto DGA, Trevisol AP, Tardelli V, Arcadepani F, Bosso RA, Ribeiro M, Fidalgo TM. Can Contingency Management solve the problem of adherence to antiretroviral therapy in drug-dependent individuals? Health Educ Behavior: Official Publication Soc Public Health Educ. 2023;50(6):738–47. https://doi.org/10.1177/10901981221148966.

Article  Google Scholar 

Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017;12(1):16. https://doi.org/10.1186/s13722-017-0081-1.

Article  PubMed  PubMed Central  Google Scholar 

Pfund RA, Ginley MK, Boness CL, Rash CJ, Zajac K, Witkiewitz K. Contingency management for drug use disorders: Meta-analysis and application of Tolin’s criteria. Clinical Psychology: Science and Practice. 2022; Suppl No Pagination Specified-No Pagination Specified.

Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (Abingdon England). 2006;101(2):192–203.

Article  PubMed  Google Scholar 

Rash CJ, Stitzer M, Weinstock J. Contingency management: new directions and remaining challenges for an evidence-based intervention. J Subst Abuse Treat. 2017;72:10–8.

Article  PubMed  Google Scholar 

Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency management interventions for HIV, Tuberculosis, and Hepatitis Control among individuals with Substance Use disorders: a systematized review. J Subst Abuse Treat. 2017;72:117–25.

Bolívar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1092–102.

Article  PubMed  Google Scholar 

Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health Professional Stigma as a barrier to Contingency Management Implementation in Opioid Treatment Programs. Translational Issues Psychol Sci. 2021;7(2):166–76.

Article  Google Scholar 

Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: how far has it come, and where does it need to go? Psychol Addict Behav. 2017;31(8):897–906.

Article  PubMed  PubMed Central  Google Scholar 

Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-target Contingency Management Intervention for HIV positive substance users. J Subst Abuse Treat. 2017;72:66–71.

Article  PubMed  Google Scholar 

Klemperer EM, Evans EA, Rawson R. A call to action: contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated. Prev Med. 2023;107647.

Bazzi AR, Drainoni ML, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, Biello KB. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19(1):31. https://doi.org/10.1186/s12889-018-6314-8.

Article  PubMed  PubMed Central  Google Scholar 

Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. (2021). PrEP just isn’t my priority: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Social science & medicine (1982), 275, 113809. https://doi.org/10.1016/j.socscimed.2021.113809

Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O. Primary care Physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav. 2017;21:1025–33.

Article  PubMed  PubMed Central  Google Scholar 

Adams LM, Balderson BH. (2016). HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care. 2016;28(9):1154–1158.

Shrestha R, Karki P, Altice FL, Huedo-Medina TB, Meyer JP, Madden L, Copenhaver M. (2017). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug Alcohol Depend. 2017;173:107–116.

Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26. https://doi.org/10.1097/MLR.0b013e3182408812.

Article  PubMed  PubMed Central  Google Scholar 

Sung ML, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, et al. Contingency Management and Pre-exposure Prophylaxis Adherence Support services (CoMPASS): a hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemp Clin Trials. 2023;125:107037.

Article  PubMed  Google Scholar 

Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2016;32(1):62–70.

Article  PubMed  PubMed Central  Google Scholar 

Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 2012;121(3):205–12.

Article  PubMed  Google Scholar 

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.

Article  PubMed  PubMed Central  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.

Article  PubMed  Google Scholar 

Oluwoye O, Weeks DL, McDonell MG. An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers’ ethnicity. BMC Health Serv Res. 2023;23(1):902.

Article  PubMed  PubMed Central  Google Scholar 

Cowie ME, Hodgins DC. Contingency Management in Canadian addiction treatment: provider a

留言 (0)

沒有登入
gif